CDC Identifies New Potential Risk of Zika Virus Transmission in Florida Counties
The Centers for Disease Control and Prevention (CDC) has identified a potential risk of Zika virus transmission starting on June, 15, 2016, to present in Miami-Dade County, Florida, that also could affect risk for residents of Broward and Palm Beach counties. CDC recently collaborated with the Florida Department of Health to conduct additional analysis of locally acquired Zika cases, including analysis of resident travel patterns between Miami-Dade, Broward, and Palm Beach counties. This analysis has led to CDC identifying that since June 15, 2016, there has been a potential increased Zika risk for residents in Broward and Palm Beach counties because of local travel to areas of active transmission in Florida and challenges associated with defining sources of exposure. This increased risk is particularly relevant for semen because of evidence regarding the persistence of Zika virus in this reproductive tissue.
This update aligns the identification of risk related to blood and tissue in the tri-county area with the time period identified in CDC travel guidance for Miami-Dade County as stated in the Health Alert Network (HAN) of Aug. 1, 2016.
This potential increased risk of Zika virus exposure associated with semen may be attributed to:
• Local transmission of Zika virus in Miami-Dade County
• Evidence confirming that Zika virus can persist in semen longer than in other body fluids
• The ongoing concern about Zika virus infections that go undiagnosed because people have mild or no symptoms
• Challenges defining the source and location of Zika virus exposure
• The regular movement of people between and within the three counties
Blood donations throughout the United States are tested for Zika with laboratory testing, resulting in the removal of Zika virus positive collections in multiple states and Puerto Rico. Testing for tissue donors, including semen donors, is not currently available; however, tissue donors are asked travel history questions, and if they have traveled to or live in an area of active Zika virus transmission they would be determined ineligible under current FDA guidance.
CDC encourages women and their partners, in consultation with their healthcare providers, to consider this potential risk when trying to conceive. Additionally, healthcare providers should counsel their pregnant patients who might have been exposed to semen from men potentially infected with Zika virus about this risk. Zika virus infection during pregnancy can cause brain abnormalities, microcephaly, and congenital Zika syndrome, a pattern of conditions in the baby that includes brain abnormalities, eye defects, hearing loss, and limb defects.
In collaboration with the Florida Department of Health, CDC has issued guidance to prevent Zika transmission for residents and visitors to the tri-county area.
Source: CDC
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
